TNFRSF9 and cancer: In fact, despite the apparent beneficial prognostic role of a high amount of Tregs in the peripheral blood, patients with high levels of CD137+ T cells compared to Tregs showed a longer survival indicating that the balance between immune activation and immune suppression is fundamental for establishing the type of immune response provoked and in determining the clinical outcome of cancer patients.